Hims & Hers Health
HIMS · NYSE
$29.21+$1.06 (+3.77%)TodayMarket closed ·
Prev close $28.15
About HIMS
- Employees
- 2,442
- Headquarters
- San Francisco, California
- Listed
- Sep 9, 2019
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Website
- forhims.com
Leadership
| Name | Title | Since |
|---|---|---|
| Andrew Dudum | — | 2016 |
| Oluyemi Okupe | — | — |
| Mike Chi | — | — |
| Nader Kabbani | — | — |
| Mo Elshenawy | — | — |
| Soleil Boughton | — | — |
| David Wells | — | — |
| Patrick Carroll | — | — |
| Deb Autor | — | — |
| Delos Cosgrove | — | — |
| Anja Manuel | — | — |
| Christopher Payne | — | — |
| Christiane Pendarvis | — | — |
| Andrea Perez | — | — |
| Kare Schultz | — | — |
Revenue by product and region
Fiscal year ended Dec 31, 2025: $2.35B total revenue
By region
- United States Revenue$2.21B94.3%
- Rest of the World Revenue$133.99M5.7%
Suppliers and customers
Price correlation is over one year: 1 means the stocks move together, -1 opposite
| Company | Relationship | Correlation |
|---|---|---|
| Amazon.com AMZN | Supplier | 0.55 |
| Apostrophe Pharmacy LLC | Supplier | — |
| XeCare LLC | Supplier | — |
Similar companies
Companies in the same industry as Hims & Hers Health
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.